Selected hematology test results (Hematology CRF) Study Description Describes the demographic, clinical, immunologic, and virologic characteristics of HIV-exposed uninfected infants and HIV-infected i
GSK2838232 is a Human Immunodeficiency Virus (HIV) maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy (ART). The primary objectives of this
1The lower and upper bounds reflect probabilities for CD4 cell counts of >500 cells/µL and 0–50 cells/µL, respectively.2Expert opinion (2009).3Costs vary by CD4 cell count, HAART usage, and history of
